HAE-AS: A Specific Disease Activity Scale for Hereditary Angioedema With C1-Inhibitor Deficiency

J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):246-252. doi: 10.18176/jiaci.0479. Epub 2020 Jan 14.

Abstract

Background and objective: The activity of hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) varies between patients and within individual patients. Objective: This study aims to develop a disease activity scale for C1-INH-HAE (HAE-AS) with sound measurement properties.

Methods: Eleven countries participated in a prospective multicenter cohort study. A clinical questionnaire was self-completed by 290 adult patients with C1-INH-HAE. Patients also completed 2 quality of life scales, the SF-36v2 and the HAE-QoL. Rasch analysis and classic psychometric methods were used to preselect a series of clinical items: number of attacks by location and number of treated attacks, emergency room visits, psychological/psychiatric treatment, missed school/workdays in the previous 6 months; general health; and impairment in everyday work/activities due to pain.

Results: The mean (SD) age was 41.5 (14.7; range, 18-84) years, and 69% were females. The final 12-item Rasch model showed that the HAE-AS had satisfactory reliability (person separation index, 0.748), local item independence, unidimensionality, and no item bias by age or sex. The HAE-AS provided scores in a linear measure, with a mean of 10.66 (3.92; range, 0-30). Further analysis with classic psychometric methods indicated that the HAE-AS linear measure presented moderate-to-high convergent validity with quality of life scales (SF-36v2: physical component, r=-0.33; mental component, 0.555; HAE-QoL, -0.61), and good discriminative validity by age, sex, and disease severity (P<.05).

Conclusions: The HAE-AS is a short, valid, reliable, and psychometrically sound measure of the activity of C1-INH-HAE that could prove useful for research studies.

Keywords: C1-INH-HAE; Clinical activity; Hereditary angioedema; Psychometric properties; Rasch analysis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Complement C1 Inhibitor Protein / genetics*
  • Disease Progression
  • Female
  • Hereditary Angioedema Types I and II / diagnosis*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Psychometrics / methods*
  • Quality of Life
  • Reproducibility of Results
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Complement C1 Inhibitor Protein